Acusensus (ASX:ACE) YoY EBITDA Growth: -581.82% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ACE Acusensus Ltd ASX:ACE
56 GF Score
Price A$1.05
GF Value A$1.50
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Acusensus YoY EBITDA Growth?

Acusensus ASX:ACE +6.09% 56 YoY EBITDA Growth is -581.82% as of Dec. 2025. GuruFocus rates ASX:ACE with a GF Score™ of 56/100 and a GF Value™ of A$1.50 (Possible Value Trap). The stock has 1 warning sign investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Acusensus's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was -581.82%.

Acusensus's EBITDA per Share for the six months ended in Dec. 2025 was A$-0.11.

Acusensus YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Acusensus's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acusensus YoY EBITDA Growth Chart

Acusensus Annual Data
Trend Jun22 Jun23 Jun24 Jun25
YoY EBITDA Growth
0.00 0.00 -10.64 -30.95

Acusensus Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial 0.00 0.00 -4.35 -65.00 -581.82
ASX:ACE
56GF Score
Acusensus Ltd ASX:ACE
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acusensus YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Acusensus's YoY EBITDA Growth for the fiscal year that ended in Jun. 2025 is calculated as:

YoY EBITDA Growth (A: Jun. 2025 )
=(EBITDA per Share (A: Jun. 2025 )-EBITDA per Share (A: Jun. 2024 ))/ | EBITDA per Share (A: Jun. 2024 ) |
=(0.029-0.042)/ | 0.042 |
=-30.95 %

Acusensus's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(-0.106-0.022)/ | 0.022 |
=-581.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -581.82% mean?
Acusensus (ASX:ACE) has a YoY EBITDA Growth of -581.82% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Acusensus and its competitors.
Is Acusensus' YoY EBITDA Growth too high?
Acusensus' current YoY EBITDA Growth is -581.82%. Overall, Acusensus has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Acusensus' YoY EBITDA Growth compare to MSFT and ORCL?
Acusensus' YoY EBITDA Growth of -581.82% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Software company?
A good YoY EBITDA Growth depends on the Software industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Acusensus and its competitors. Acusensus's current YoY EBITDA Growth is -581.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.50, compared to a current price of A$1.05 — trading 30.3% below its estimated fair value. The current YoY EBITDA Growth is -581.82%. Acusensus' overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current YoY EBITDA Growth is -581.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acusensus (ASX:ACE) Overvalued in 2026?

Based on GuruFocus' analysis, Acusensus stock appears to be undervalued. The current stock price of A$1.05 is trading 30.3% below its estimated GF Value™ of A$1.50. GuruFocus considers Acusensus to be Possible Value Trap.

Key valuation signals for ASX:ACE:

  • YoY EBITDA Growth: -581.82%
  • GF Value™: A$1.50 vs. price of A$1.05 (30.3% below fair value)
  • GF Score™: 56/100 with 1 warning sign

No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acusensus Business Description

Address 31 Queen Street, Level 1, Melbourne, VIC, AUS, 3000
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
56GF Score

Get the complete analysis for ASX:ACE

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.05
Price
A$1.50
GF Value